VANCOUVER, British Columbia, March 8, 2012 (GLOBE NEWSWIRE) -- QLT Inc. (Nasdaq:QLTI) (TSX:QLT) will be presenting at the ROTH Capital Partners Growth Stock Conference in Laguna Niguel, CA, on Tuesday, March 13, 2012, at 3:30 p.m. Pacific Time. Bob Butchofsky, QLT's President and Chief Executive Officer, will be discussing the Company's two primary development programs: (i) a synthetic retinoid, QLT091001, for the treatment of Leber Congenital Amaurosis and Retinitis Pigmentosa; and (ii) the Company's Punctal Plug Delivery System primarily for the treatment of glaucoma.
